Medical News

RSS

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results as at and for the three-month and nine-month periods ended September 30, 2009.

11 Nov 2009

GeneNews discloses financial results for third-quarter 2009

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today reported operational and financial results for the third quarter-ended September 30, 2009.

11 Nov 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products for different spine therapy areas at the North American Spine Society (NASS) 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California. To date MagniFuse has been used in 40 spinal surgeries in the United States

11 Nov 2009

TripleTree announces Ingenix' acquisition of CareMedic

TripleTree is pleased to announce that its client, CareMedic, an industry leader in revenue cycle management (RCM) solutions, will be acquired by Ingenix, a leading health information, technology and consulting company, in a cash transaction.

11 Nov 2009

1-800-DENTIST calls for "voting for your favorite story", an initiative to spread the importance of dentistry

1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.

11 Nov 2009

Pan-African conference to focus on the rapid growth of diabetes in Africa

The Republic of Mauritius in collaboration with the World Health Organization Afro Region and the International Diabetes Federation (IDF) today opened an International Conference on Diabetes & Associated Diseases in Port Louis, Mauritius to highlight their concern about the rapid growth of the diabetes epidemic throughout Africa. The conference will run from November 12 and end on November 14 – World Diabetes Day.

11 Nov 2009

Majority of U.S. Army Special Forces Operators do not seek PTSD treatment

According to a University of the Rockies study, more than half (54.4 percent) of U.S. Army Special Forces Operators exposed to combat would not seek treatment while serving in the Army, even if they were experiencing Posttraumatic Stress Disorder (PTSD) symptoms or psychological distress.

11 Nov 2009

Glissandra Skincare launches three signature anti-aging products

Glissandra™ Skincare Inc. announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund’s “Women of Action” awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.

11 Nov 2009

TSO3 reports third quarter 2009 financial results

TSO3 Inc. ("TSO3") posted revenues of $126,162 on the sales of consumables and service for the third quarter ended September 30, 2009. There were no new shipments of sterilizers in third quarter.

11 Nov 2009

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

The holidays should be a time when Americans focus on celebrating, reuniting with loved ones, enjoying holiday feasts and seemingly endless holiday treats. But, for the roughly 127 million Americans that struggle with maintaining healthy blood sugar and cholesterol levels, the stress of nearly two months of festivities can place enormous pressure on a body’s ability to maintain normal blood sugar and cholesterol levels.

11 Nov 2009

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

Sol-Gel Technologies announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel’s Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.

11 Nov 2009

PRI's risk management conference focuses on public policy and future trends in medical malpractice

Physicians’ Reciprocal Insurers (PRI), the second largest medical malpractice insurer in New York state, today announced that it will host its Ninth Annual Risk Management Conference on Tuesday, November 17 at the Helmsley Hotel in New York City.

11 Nov 2009

Butterfly experiment in space

When NASA's space shuttle Atlantis launches for the International Space Station on Nov. 16 it will carry a University of Colorado at Boulder butterfly experiment that will be monitored by thousands of K-12 students across the nation.

11 Nov 2009

Vertex Pharmaceuticals announces exchange agreement with holders of its 4.75% Convertible Senior Subordinated Notes

Vertex Pharmaceuticals Incorporated announced today that holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal amount of those notes and accrued interest for approximately 4.8 million shares of the Company’s common stock, which is approximately 140,000 shares more than the number of shares into which the notes were convertible under their original terms.

11 Nov 2009

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

iiBIG and the newly formed Global Biopharmaceutical Advisory Board have jointly planned an event that will focus on one of the most dynamic trends in the pharmaceutical, biotechnology, and medical device industries -- strategic outsourcing. Biopharma CEOs, VPs of Global Operations, and Department Heads will meet at the 4th Annual Global Clinical Trial Partnerships, March 1-2, 2010, in Princeton, New Jersey to discuss the latest strategies for optimizing global operations.

11 Nov 2009

Engineers develop technology to ensure "right first time" drug crystal formation in existing chemical reactors

Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation.

11 Nov 2009

Report on the U.S. Government's drive for comparative effectiveness research

MarketResearch.com has announced the addition of GlobalData's new report "The US Government's Financial Support to Push Comparative Effectiveness Research," to their collection of Healthcare market reports.

11 Nov 2009

NASDAQ grants InfoLogix's request for exception to stockholder approval requirements

InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that NASDAQ has granted the Company's request for an exception to NASDAQ's stockholder approval requirements, in accordance with NASDAQ Listing Rule 5635(f).

11 Nov 2009

Cancer screening methods are not perfect: Experts

In a recent New York Times article, the American Cancer Society (ACS) ignited a major controversy over the benefits of cancer screening, specifically with regards to their breast and prostate cancer guidelines. In the article, Dr. Otis Brawley, chief medical officer of the ACS, responded to a study in the current issue of the Journal of the American Medical Association.

11 Nov 2009

Medical News

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Aeterna Zentaris reports consolidated revenues of $8.6 million for third quarter 2009

GeneNews discloses financial results for third-quarter 2009

Osteotech highlights Magnifuse bone grafting products at NASS Annual Meeting

TripleTree announces Ingenix' acquisition of CareMedic

1-800-DENTIST calls for "voting for your favorite story", an initiative to spread the importance of dentistry

Pan-African conference to focus on the rapid growth of diabetes in Africa

Majority of U.S. Army Special Forces Operators do not seek PTSD treatment

Glissandra Skincare launches three signature anti-aging products

TSO3 reports third quarter 2009 financial results

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel

PRI's risk management conference focuses on public policy and future trends in medical malpractice

Butterfly experiment in space

Vertex Pharmaceuticals announces exchange agreement with holders of its 4.75% Convertible Senior Subordinated Notes

Biopharma leaders to discuss optimized clinical operations and outsourcing strategies at iiBIG's forum

Engineers develop technology to ensure "right first time" drug crystal formation in existing chemical reactors

Report on the U.S. Government's drive for comparative effectiveness research

NASDAQ grants InfoLogix's request for exception to stockholder approval requirements

Cancer screening methods are not perfect: Experts

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News